These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34410012)

  • 1. Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11-deficient mice.
    Wang L; Luo Q; Zeng S; Lou Y; Li X; Hu M; Lu L; Liu Z
    J Pathol; 2021 Dec; 255(4):412-424. PubMed ID: 34410012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.
    Chen Y; Song X; Valanejad L; Vasilenko A; More V; Qiu X; Chen W; Lai Y; Slitt A; Stoner M; Yan B; Deng R
    Hepatology; 2013 Apr; 57(4):1530-41. PubMed ID: 23213087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice.
    El Kasmi KC; Ghosh S; Anderson AL; Devereaux MW; Balasubramaniyan N; D'Alessandro A; Orlicky DJ; Suchy FJ; Shearn CT; Sokol RJ
    Hepatology; 2022 Feb; 75(2):252-265. PubMed ID: 34387888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic preconditioning protects BSEP/ABCB11
    Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
    J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
    Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
    Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump.
    Plass JR; Mol O; Heegsma J; Geuken M; Faber KN; Jansen PL; Müller M
    Hepatology; 2002 Mar; 35(3):589-96. PubMed ID: 11870371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
    Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
    Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    Zhang F; Xi L; Duan Y; Qin H; Wei M; Wu Y; Li B; Zhou Y; Wu X
    Eur J Pharm Sci; 2018 Oct; 123():404-415. PubMed ID: 30077711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.
    Kim YC; Jung H; Seok S; Zhang Y; Ma J; Li T; Kemper B; Kemper JK
    Hepatology; 2020 Jun; 71(6):2118-2134. PubMed ID: 31549733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The choleretic role of tauroursodeoxycholic acid exacerbates alpha-naphthylisothiocyanate induced cholestatic liver injury through the FXR/BSEP pathway.
    Zhao J; Song G; Weng F; Li Y; Zou B; Jin J; Yan D; Sun X; Liu C; Qiu FR
    J Appl Toxicol; 2023 Jul; 43(7):1095-1103. PubMed ID: 36787806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.
    Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ
    J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice.
    Fuchs CD; Krivanec S; Steinacher D; Mlitz V; Wahlström A; Stahlman M; Claudel T; Scharnagl H; Stojakovic T; Marschall HU; Trauner M
    Liver Int; 2020 Jun; 40(6):1366-1377. PubMed ID: 32141703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters.
    Sissung TM; Huang PA; Hauke RJ; McCrea EM; Peer CJ; Barbier RH; Strope JD; Ley AM; Zhang M; Hong JA; Venzon D; Jackson JP; Brouwer KR; Grohar P; Glod J; Widemann BC; Heller T; Schrump DS; Figg WD
    Mol Pharmacol; 2019 Aug; 96(2):158-167. PubMed ID: 31175181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
    Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J
    J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway.
    Sheng Y; Meng G; Zhang M; Chen X; Chai X; Yu H; Han L; Wang Q; Wang Y; Jiang M
    J Ethnopharmacol; 2024 Aug; 330():118209. PubMed ID: 38663779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor.
    Frankenberg T; Miloh T; Chen FY; Ananthanarayanan M; Sun AQ; Balasubramaniyan N; Arias I; Setchell KD; Suchy FJ; Shneider BL
    Hepatology; 2008 Dec; 48(6):1896-905. PubMed ID: 18668687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
    Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P
    Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters.
    Xue H; Fang S; Zheng M; Wu J; Li H; Zhang M; Li Y; Wang T; Shi R; Ma Y
    J Ethnopharmacol; 2021 Apr; 269():113706. PubMed ID: 33346024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleanolic acid induces hepatic injury by disrupting hepatocyte tight junction and dysregulation of farnesoid X receptor-mediated bile acid efflux transporters.
    Zeng L; Huang J; Wang Y; Hu Y; Zhou S; Lu Y
    J Appl Toxicol; 2024 Nov; 44(11):1725-1741. PubMed ID: 39030772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.